Recombinant Human Translocation protein SEC62 (SEC62)

What is SEC62 and what are its primary cellular functions?

SEC62 is a membrane protein component of the translocon complex located in the endoplasmic reticulum (ER). Its primary functions include:

• Facilitating protein translocation across the ER membrane during protein synthesis

• Regulating ER homeostasis during stress recovery through ER-phagy mechanisms

• Participating in calcium homeostasis within the cell

Research methodologies for studying these functions typically involve cellular fractionation to isolate ER components, co-immunoprecipitation to identify protein-protein interactions, and fluorescence microscopy to visualize SEC62 localization . The protein contains specific domains including a LIR (LC3-interacting region) that mediates interaction with autophagy machinery, which has been validated through both in silico predictions and in vitro binding assays .

How is SEC62 expression regulated in normal versus pathological conditions?

Methodological approach to studying this regulation:

• Compare SEC62 expression levels between normal and cancerous tissues using western blotting and immunohistochemistry

• Correlate expression with clinical outcomes through multivariate analysis

• Implement genomic analyses to identify potential amplification events

In hepatocellular carcinoma (HCC), high expression of SEC62 has been positively correlated with surgical recurrence. Multivariate analysis has revealed that SEC62 serves as an independent prognostic factor for early recurrence in postoperative HCC patients . Similar findings have been documented in head and neck squamous cell carcinoma (HNSCC), where SEC62 amplification has been observed at both chromosomal and protein levels .

What experimental models are most effective for studying SEC62 function?

Several experimental models have proven valuable for investigating SEC62 function:

For generating SEC62 knockout cell lines, CRISPR/Cas9 technology has been successfully employed. For example, FaDu wild type cells have been transfected with plasmids containing guide RNA targeting SEC62, followed by puromycin selection and single cell clone isolation. Knockout validation requires both DNA sequencing (NGS) and protein analysis (western blotting) .

What are the molecular mechanisms through which SEC62 promotes cancer metastasis?

SEC62 promotes cancer cell migration and invasion through multiple signaling pathways, with integrinα/CAV1 signaling being particularly well-characterized. The methodological approach to elucidate these mechanisms includes:

• Comparative microarray analysis between SEC62 overexpression (SEC62^OE) and SEC62 knockdown (SEC62^KD) cells to identify differentially expressed genes

• Pathway analysis to identify enriched signaling networks

• Functional validation through rescue experiments

In HCC, SEC62 overexpression has been shown to enhance cell migration and invasion in vitro, and promote postsurgical recurrence in vivo. Mechanistically, integrinα/CAV1 signaling was identified as a target of SEC62 in regulating cell movement. The functional relationship was validated by demonstrating that overexpression of integrin α partially rescued the inhibition of cell migration induced by SEC62 knockdown .

How does SEC62 knockout affect cellular phenotypes, and what methodological considerations are important?

SEC62 knockout generates significant phenotypic alterations in cancer cells that can be experimentally measured. Key methodological considerations include:

• Confirmation of knockout efficiency through multiple methods

• Real-time monitoring of cellular behaviors

• Standardization of experimental conditions across control and knockout lines

In HNSCC FaDu cells, SEC62 knockout via CRISPR/Cas9 technology resulted in:

• Significantly reduced proliferation rates as measured by xCELLigence system (clone1: p = 0.0095; clone2: p = 3.34e-4 compared to wild type)

• Markedly decreased migratory potential assessed using the FluoroBlok system

• Altered response to therapeutic agents targeting SEC62-dependent pathways

The validation of SEC62 knockout requires comprehensive approaches. In the case of FaDu cells, next-generation sequencing revealed five different alleles in one clone after Cas9 activity, with the most abundant allele showing an insertion of a cytosine before the PAM sequence (36% of reads). Western blot analysis confirmed nearly undetectable SEC62 protein levels in both knockout clones (clone1: 0.04 ± 0.03; clone2: 0.03 ± 0.02 compared to wild type) .

What is the role of SEC62 in ER stress recovery and autophagy?

SEC62 plays a critical role in endoplasmic reticulum turnover during stress recovery through a specialized form of autophagy called ER-phagy. Methodological approaches to studying this function include:

• Induction of ER stress using chemical agents (e.g., thapsigargin)

• Monitoring ER recovery through microscopy and biochemical assays

• Manipulation of autophagy using inhibitors (e.g., Bafilomycin A1)

• Analysis of protein-protein interactions between SEC62 and autophagy machinery

The LC3-interacting region (LIR) in the cytosolic domain of SEC62 is crucial for this function. Research has shown that SEC62 associates with endogenous LC3-II in living cells in a LIR-dependent manner, and this association is stabilized with Bafilomycin A1 treatment. Importantly, this interaction does not require SEC63, another translocon component .

What therapeutic strategies targeting SEC62 show promise for cancer treatment?

Based on SEC62's role in promoting cancer cell proliferation and metastasis, several therapeutic approaches have been investigated:

The orthotopic HNSCC murine xenograft model has proven valuable for investigating the potential anti-proliferative and anti-metastatic effects of compounds like thapsigargin (TG) and trifluoperazine (TFP) that counteract SEC62 function . These agents have shown promise in in vitro functional assays, suggesting SEC62 might be an attractive drug target for combating postsurgical recurrence in cancers with SEC62 overexpression.

What techniques are most effective for studying SEC62 protein interactions and complex formation?

Several complementary techniques have proven valuable for investigating SEC62's interactions:

• Co-immunoprecipitation (co-IP): Effective for detecting stable protein-protein interactions

  • Successfully used to demonstrate SEC62's LIR-dependent association with endogenous LC3-II

  • Can be performed with endogenous or ectopically expressed proteins

• Domain mapping and mutagenesis:

  • The cytosolic LIR-containing domain of SEC62 can be appended to ER membrane-anchored GFP (GFPTM62) to study specific domain functions

  • Mutation of the SEC62 LIR abolishes association with both endogenous and recombinant LC3

• Genetic approaches:

  • Utilizing ATG7 knockout MEFs with inactive autophagy demonstrated that SEC62-LC3 interactions require functional autophagy machinery

  • SEC63 knockout models showed that SEC62's association with LC3-II does not require SEC63

• Structural studies:

  • In silico analysis combined with in vitro binding assays have confirmed the functionality of SEC62's LIR domain

  • These approaches helped identify critical residues for protein-protein interactions

What are the optimal techniques for generating and validating SEC62 knockout cell lines?

Generating reliable SEC62 knockout cell lines requires careful methodological considerations:

• CRISPR/Cas9 design:

  • Selection of appropriate guide RNA sequences targeting SEC62 (e.g., 5'-CTG TGG TTG ACT ACT GCA AC-3')

  • Use of established vectors like lentiCRISPRv2-puro system

  • Transfection optimization for target cell lines

• Clone selection process:

  • Application of puromycin selection pressure (e.g., 1.5 μg/ml)

  • Single cell isolation and colony expansion

  • Multiple rounds of selection to ensure monoclonality

• Comprehensive validation:

  • Next-generation sequencing to confirm genetic modifications

  • Western blotting to verify protein depletion

  • Functional assays to confirm phenotypic changes

In the case of FaDu cells, NGS revealed that after CRISPR/Cas9 targeting, 88.5% of analyzed reads in clone 1 differed from the reference genome, with the most common modification being a cytosine insertion before the PAM sequence. Western blot analysis confirmed that remaining SEC62 protein levels were nearly undetectable in both validated clones (0.04 ± 0.03 and 0.03 ± 0.02 compared to wild type) .

What assays are most informative for studying SEC62's role in cell migration and invasion?

Several complementary assays provide valuable insights into SEC62's role in cell motility:

These assays have revealed that SEC62 knockout significantly impairs both proliferation and migration of cancer cells. For instance, when comparing wild-type and SEC62 knockout FaDu cells, a pronounced reduction in migratory potential was observed and quantified by counting migrated cells in multiple fields after DAPI staining .

What are the emerging areas of investigation regarding SEC62's roles beyond the currently established functions?

Several promising research directions are emerging:

• SEC62's role in immune evasion:

  • How SEC62 overexpression might affect tumor-immune interactions

  • Potential impact on immunotherapy response

  • Methodological approaches combining SEC62 manipulation with immune co-culture systems

• SEC62 in therapy resistance:

  • Mechanisms by which SEC62-mediated ER homeostasis might contribute to stress adaptation

  • Potential synergistic effects of SEC62 inhibition with conventional therapies

  • Screening approaches to identify synthetic lethality partners

• SEC62 post-translational modifications:

  • Identification of regulatory modifications affecting SEC62 function

  • Development of site-specific antibodies to track modified forms

  • Mass spectrometry-based approaches for comprehensive modification mapping

• SEC62 in non-cancer pathologies:

  • Expanding research beyond oncology to other ER stress-related diseases

  • Studying SEC62 function in neurodegenerative conditions

  • Animal models with tissue-specific SEC62 modulation

Each of these directions requires development of new methodological approaches and experimental models to fully elucidate SEC62's complex roles in cellular biology.

How can researchers integrate multiple approaches to develop a comprehensive understanding of SEC62 biology?

Developing a complete picture of SEC62 biology requires integration of diverse research approaches:

• Combine genetic manipulation (knockouts, mutations) with functional assays to establish causality

• Correlate basic research findings with clinical observations to ensure relevance

• Utilize both in vitro and in vivo models to validate key findings

• Apply systems biology approaches to place SEC62 within broader cellular networks

• Develop computational models to predict SEC62 behavior under various conditions

SEC62 represents an important research target with significant implications for understanding both fundamental cell biology and disease mechanisms. The protein's dual roles in protein translocation and ER-phagy position it at a critical intersection of cellular homeostasis pathways. Furthermore, its emerging functions in cancer progression make it a promising therapeutic target.